ARS Pharma
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
11682 El Camino Real Ste 300, San Diego,...Phone Number
(858) 771-9307Website
www.ars-pharma.comRevenue
$99 MillionStock Symbol
SPRYIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About ARS Pharma
ARS Pharm operates as a pharmaceutical company. The Company develops an intranasal epinephrine spray with a unique absorption technology to save patients from allergic reactions of food, medications, and insect bites. Established in 2015, ARS Pharm is headquartered in San Diego, California, United States.Explore more
ARS Pharma Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is ARS Pharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on ARS Pharma recently announced quarterly report
Click to see if ARS Pharma had a recent Job posting/layoffs
Check if ARS Pharma has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when ARS Pharma launches new products
Website visits: Recent activity has been detected on your website
ARS Pharma, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if ARS Pharma is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at ARS Pharma
Funding: Get notified immidiatlly once ARS Pharma has new funding data
Recommended Actions
Reach out to Masked Content who joined ARS Pharma as Masked Content
Find 2 more new buyers
Compare Similar Companies to ARS Pharma
Compare insights from companies similar to ARS Pharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
ARS Pharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
ARS Pharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about ARS Pharma.
ARS Pharma financials insights
Gather financial insights about ARS Pharma, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2018
Series C
$20M
2021
Series D
$55M
ARS Pharma Tech Stack
A closer look at the technologies used by ARS Pharma
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Promotion
Executive Move
Donn Casale, President, has assumed the additional role of Chief Executive Officer & Board Director.
Executive Moves, Promotion, Board of Directors
Left Company
Executive Move
Executive Moves, Left Company
Person-Based
Business Finance, Finance, Financial Operations
Person-Based
Advertising
ARS Pharma News & Media
SPRY Investor Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Lawsuit Against ARS Pharmaceuticals Inc.
SAN DIEGO, Aug. 7, 2026 /PRNewswire/ -- Robbins LLP reminds shareholders that a securities class action has been filed on behalf of all investors who purchased or otherwise acquired ARS Pharmaceuticals Inc. (NASDAQ: SPRY) securities between March 9, 2026 and June 24, 2026 (the "Class...SPRY Investors Have Opportunity to Lead ARS Pharmaceuticals, Inc. Securities Fraud Lawsuit
NEW YORK, Aug. 6, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) between March 9, 2026 and June 24, 2026, inclusive (the "Class Period"). A...SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of October 5, 2026 in ARS Pharmaceuticals Inc. Lawsuit - SPRY
Wall Street called the missed CVS Caremark formulary date a "negative shock" — a securities class action alleges ARS Pharmaceuticals built analyst expectations on a July 1, 2026 coverage timeline that was never disclosed as at risk of slipping to January 2027. NEW YORK, Aug. 6, 2026...Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed ARS Pharmaceutic (SPRY)
NEW YORK, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the Southern District of California on behalf of all persons or entities who purchased or otherwise acquired ARS Pharmaceuticals Inc. (ARS Pharm. or the “Company”) (NASDAQ: SPRY) securities between March 9, 2026 and June 24, 2026, inclusive (the “Class Period”).
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding ARS Pharma
Sign Up For FreeTo access detailed company insights
ARS Pharm operates as a pharmaceutical company. The Company develops an intranasal epinephrine spray with a unique absorption technology to save patients from allergic reactions of food, medications, and insect bites. Established in 2015, ARS Pharm is headquartered in San Diego, California, United States.... Read More
